auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Purpose
Providence Therapeutics, Canada’s leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. The company is in the R&D phases to demonstrate the preclinical and clinical efficacy of PTX-COVID19-B.
Providence Therapeutics Holdings Inc. × National Research Council Canada
7 grants totalling $46.5M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $111.3M